Ledger.Open graph →
SEC Form D · filed November 7, 2022

PharmaCann Inc

Offering
$25.0M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Other
Location
CHICAGO, IL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

David P. Chiovetti · Chicago, ILExecJohn P. Lord · Chicago, ILDirectorJames P. Barry · Chicago, ILDirectorBrett Novey · Chicago, ILExec · DirectorLori P. Richards · Chicago, ILDirectorDaniel P. Roth · Chicago, ILExecPatrick P. Unzicker · Chicago, ILExecRobert P. Mcqueen · Chicago, ILExecJohn P. Mccarthy · Chicago, ILDirectorStephen P. Schuler · Chicago, ILDirectorMark Mccurdy, M.D · Fort Worth, TXDirectorJeff N. Lucassen · TORONTO, Ontario, CanadaDirectorJeff Spain · Rialto, CAExecIan Balina · Beaverton, ORDirectorRafael La Porta De Castro · Rialto, CADirectorAndrew T. Messer · Jacksonville, FLExec · DirectorJeffrey N. Pentland · TORONTO, Ontario, CanadaExecAjith Pai · Fort Worth, TXExecJustin J. Dennis · Jacksonville, FLDirectorKatherine N. Gurney · TORONTO, Ontario, CanadaExecBruce R. Jenkyn-Jones · London, United KingdomDirectorEdward Shehwen · Mt. Laurel, NJExec · DirectorParent of the General Partner Richard Impax Asset Management Group PLC · London, United KingdomDirectorKen Johnson · Mt. Laurel, NJExecBernd B. Gottschalk · Pleasanton, CAExecNicholas Edwards · Fargo, NDExecJonathon B. Husby · Pleasanton, CADirectorJeff Mcdermott · Fargo, NDDirectorMatthew Fisch · Pleasanton, CADirectorConor B. Tierney · Pleasanton, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗